GOLO’s Release Supplement

Case Name (Date)

Bubak et al v. GOLO, LLC
21-cv-492, E.D. Cal.
(March 2021)

Product/Service

GOLO’s Release Supplement

Allegations

Implying that the supplement mitigates and prevents diabetes, heart disease, and Alzheimer’s disease by claiming that it is “the Natural Solution to Insulin Resistance”

Misleadingly marketing the supplement as “Clinically Proven” when the company relies on pilot studies that it paid for and that have not been peer reviewed or published in legitimate scientific publications

Status

Pending